FOLH1 and neoplasm: Kumar et al. described a patient who was pre-treated with surgery, radiotherapy and temozolomide and who underwent 3 cycles of 177Lu-PSMA (each 3.7 GBq); the restaging MRI revealed tumor shrinkage and minimal residual enhancement.